Fluvoxamine, a selective serotonin reuptake inhibitor, suppresses tetrahydrobiopterin levels and dopamine as well as serotonin turnover in the mesoprefrontal system of mice

Psychopharmacology (Berl). 2005 Jan;177(3):307-14. doi: 10.1007/s00213-004-1959-7. Epub 2004 Jul 29.

Abstract

Rationale: Tetrahydrobiopterin (BH4) is a coenzyme of tyrosine hydroxylase (TH) and tryptophan hydroxylase (TPH), rate-limiting enzymes of monoamine biosynthesis. According to the monoamine hypothesis of depression, antidepressants will restore the function of the brain monoaminergic system, and BH4 concentration.

Objective: To investigate the effects of fluvoxamine on BH4 levels and dopamine (DA) and serotonin (5-HT) turnover in the mesoprefrontal system, incorporating two risk factors of depression, social isolation and acute environmental change.

Methods: Male ddY mice (6W) were divided into two housing groups, i.e. group-housing (eight animals per cage; 35 days), and isolation-housing (one per cage; 35 days), SC injected with fluvoxamine (20 or 40 mg/kg; days 29-35), and exposed to 20-min novelty stress (day 35). The levels of BH4, DA, homovanilic acid (HVA), 5-HT, and 5-hydroxyindoleacetic acid (5-HIAA) were measured in the prefrontal cortex and midbrain.

Results: Under the group-housing condition, novelty stress significantly increased BH4 levels in both regions, and the HVA/DA ratio in the midbrain, whereas it did not change any parameters in either region under the isolation-housing condition. In the prefrontal cortex, fluvoxamine significantly decreased the 5-HIAA/5-HT ratio under the group-housing condition, and BH4 levels and the HVA/DA ratio under the isolation-housing condition. In the midbrain, fluvoxamine significantly decreased all parameters, except for an increasing in the 5-HIAA/5-HT ratio under the isolation-housing condition.

Conclusion: Isolation-housing suppressed the increase of BH4 levels and DA turnover elicited by novelty stress. Fluvoxamine suppressed BH4 levels, and DA and 5-HT turnover. Fluvoxamine may have altered DA turnover by suppressing BH4 levels.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Biopterins / analogs & derivatives*
  • Biopterins / antagonists & inhibitors
  • Biopterins / chemistry
  • Biopterins / metabolism
  • Depressive Disorder / drug therapy
  • Depressive Disorder / etiology
  • Dopamine / chemistry*
  • Dopamine / metabolism
  • Fluvoxamine / administration & dosage
  • Fluvoxamine / pharmacokinetics*
  • Housing, Animal
  • Injections, Subcutaneous
  • Male
  • Membrane Glycoproteins / drug effects
  • Membrane Glycoproteins / metabolism
  • Membrane Transport Proteins / drug effects
  • Membrane Transport Proteins / metabolism
  • Mesencephalon / chemistry
  • Mesencephalon / drug effects
  • Mesencephalon / metabolism
  • Mice
  • Mice, Inbred Strains
  • Nerve Tissue Proteins / drug effects
  • Nerve Tissue Proteins / metabolism
  • Prefrontal Cortex / chemistry*
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / metabolism
  • Selective Serotonin Reuptake Inhibitors / administration & dosage
  • Selective Serotonin Reuptake Inhibitors / pharmacokinetics*
  • Serotonin / chemistry*
  • Serotonin / metabolism
  • Serotonin Plasma Membrane Transport Proteins
  • Social Isolation / psychology

Substances

  • Membrane Glycoproteins
  • Membrane Transport Proteins
  • Nerve Tissue Proteins
  • Serotonin Plasma Membrane Transport Proteins
  • Serotonin Uptake Inhibitors
  • Slc6a4 protein, mouse
  • Biopterins
  • Serotonin
  • sapropterin
  • Fluvoxamine
  • Dopamine